Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.
Torigen Pharmaceuticals has raised $13.0M in total funding. The most recent round was Series A. The last funding was announced in May 2022.
Torigen Pharmaceuticals's investors include Gaingels, Connecticut Innovations, Everywhere Ventures, Propel(X), University of Notre Dame.
Torigen Pharmaceuticals is headquartered in Farmington, United States.
Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.
Torigen Pharmaceuticals is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Torigen Pharmaceuticals — Funding & Investors." VCBacked, May 24, 2022, https://www.vcbacked.co/company/torigen-pharmaceuticals. Accessed August 14, 2026.
VCBacked. (2022). Torigen Pharmaceuticals — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/torigen-pharmaceuticals
{{cite web |title=Torigen Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/torigen-pharmaceuticals |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated